JP2021532110A5 - - Google Patents
Info
- Publication number
- JP2021532110A5 JP2021532110A5 JP2021503531A JP2021503531A JP2021532110A5 JP 2021532110 A5 JP2021532110 A5 JP 2021532110A5 JP 2021503531 A JP2021503531 A JP 2021503531A JP 2021503531 A JP2021503531 A JP 2021503531A JP 2021532110 A5 JP2021532110 A5 JP 2021532110A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical preparation
- approximately
- pharmaceutical formulation
- pharmaceutical
- physically stable
- Prior art date
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023194827A JP7738046B2 (ja) | 2018-07-30 | 2023-11-16 | 組換えヒト副甲状腺ホルモンの安定性を向上させるための製剤 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862711767P | 2018-07-30 | 2018-07-30 | |
| US62/711,767 | 2018-07-30 | ||
| PCT/US2019/041609 WO2020028011A1 (en) | 2018-07-30 | 2019-07-12 | Formulations for improved stability of recombinant human parathyroid hormone |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023194827A Division JP7738046B2 (ja) | 2018-07-30 | 2023-11-16 | 組換えヒト副甲状腺ホルモンの安定性を向上させるための製剤 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2021532110A JP2021532110A (ja) | 2021-11-25 |
| JPWO2020028011A5 JPWO2020028011A5 (https=) | 2022-07-21 |
| JP2021532110A5 true JP2021532110A5 (https=) | 2022-07-21 |
| JP7399382B2 JP7399382B2 (ja) | 2023-12-18 |
Family
ID=69232628
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021503531A Active JP7399382B2 (ja) | 2018-07-30 | 2019-07-12 | 組換えヒト副甲状腺ホルモンの安定性を向上させるための製剤 |
| JP2023194827A Active JP7738046B2 (ja) | 2018-07-30 | 2023-11-16 | 組換えヒト副甲状腺ホルモンの安定性を向上させるための製剤 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023194827A Active JP7738046B2 (ja) | 2018-07-30 | 2023-11-16 | 組換えヒト副甲状腺ホルモンの安定性を向上させるための製剤 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20210315978A1 (https=) |
| EP (1) | EP3829625A4 (https=) |
| JP (2) | JP7399382B2 (https=) |
| KR (1) | KR20210038618A (https=) |
| CN (1) | CN112638407A (https=) |
| AU (1) | AU2019315807B2 (https=) |
| CA (1) | CA3107105A1 (https=) |
| TW (1) | TWI831813B (https=) |
| WO (1) | WO2020028011A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102885113B1 (ko) | 2018-10-18 | 2025-11-13 | 머크 샤프 앤드 돔 엘엘씨 | 항-rsv 항체의 제제 및 그의 사용 방법 |
| CN120842406A (zh) | 2018-10-31 | 2025-10-28 | 默沙东有限责任公司 | 抗人pd-1抗体晶体及其使用方法 |
| US20230190880A1 (en) * | 2020-03-30 | 2023-06-22 | Sichuan Luzhou Buchang Bio-Pharmaceutical Co., Ltd. | Formulations of Human Parathyroid Hormone (PTH) and Methods for Producing Same |
| WO2025032376A1 (en) * | 2023-08-04 | 2025-02-13 | Precise Biopharma Pvt Ltd | A room temperature stable solution for injection of abaloparatide |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5496801A (en) * | 1993-12-23 | 1996-03-05 | Allelix Biopharmaceuticals Inc. | Parathyroid hormone formulation |
| EP1030658A1 (en) | 1997-10-14 | 2000-08-30 | Eli Lilly And Company | Method of building and maintaining bone |
| KR100700869B1 (ko) * | 2005-06-03 | 2007-03-29 | 재단법인 목암생명공학연구소 | Ｐｔｈ, 완충제 및 안정제를 포함하는 안정한 ｐｔｈ조성물 |
| CN100553674C (zh) * | 2007-02-02 | 2009-10-28 | 重庆科润生物医药研发有限公司 | 一种重组人甲状旁腺激素(1-84)药物组合物及其制备方法 |
| EP2052736A1 (en) * | 2007-10-26 | 2009-04-29 | Nycomed Danmark ApS | Parathyroid hormone formulations und uses thereof |
| WO2013108235A1 (en) * | 2012-01-20 | 2013-07-25 | Lupin Limited | Stabilized pth formulation |
-
2019
- 2019-07-12 JP JP2021503531A patent/JP7399382B2/ja active Active
- 2019-07-12 CA CA3107105A patent/CA3107105A1/en active Pending
- 2019-07-12 EP EP19844940.7A patent/EP3829625A4/en active Pending
- 2019-07-12 US US17/264,720 patent/US20210315978A1/en active Pending
- 2019-07-12 WO PCT/US2019/041609 patent/WO2020028011A1/en not_active Ceased
- 2019-07-12 KR KR1020217005582A patent/KR20210038618A/ko not_active Ceased
- 2019-07-12 CN CN201980056225.XA patent/CN112638407A/zh active Pending
- 2019-07-12 AU AU2019315807A patent/AU2019315807B2/en active Active
- 2019-07-30 TW TW108126918A patent/TWI831813B/zh active
-
2023
- 2023-11-16 JP JP2023194827A patent/JP7738046B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2405994T3 (es) | Soluciones estabilizadas de teriparatide | |
| ES2533601T3 (es) | Nueva composición que comprende glucagón | |
| ES2363272T3 (es) | Formulaciones de la hormona paratiroidea y utilizaciones de la misma. | |
| JP2021532110A5 (https=) | ||
| KR102327754B1 (ko) | 안정한 펩티드 제형물 및 제조 방법 | |
| KR102018998B1 (ko) | 신속-작용 인슐린 조성물 | |
| JP7738046B2 (ja) | 組換えヒト副甲状腺ホルモンの安定性を向上させるための製剤 | |
| CN108135841A (zh) | Il-2的药物组合物 | |
| US20200222508A1 (en) | Glucagon-like peptide 1 (glp-1) receptor agonist compositions | |
| EP3423042B1 (en) | A lyophilised pharmaceutical formulation and its use | |
| US20240293515A1 (en) | Stable liquid formulations of glucagon-like peptide 1 or analogues thereof | |
| JPWO2020028011A5 (https=) | ||
| KR102954604B1 (ko) | 인간 부갑상선 호르몬(pth)의 제형 및 그 제조 방법 | |
| HK40050341A (en) | Formulations for improved stability of recombinant human parathyroid hormone | |
| US20230190880A1 (en) | Formulations of Human Parathyroid Hormone (PTH) and Methods for Producing Same | |
| RU2022128012A (ru) | Жидкие составы белков, содержащие средства для снижения вязкости | |
| JP2023507890A (ja) | メシル酸ジヒドロエルゴタミン製剤およびその治療的送達のための事前充填注射器 | |
| WO2019040904A1 (en) | STORAGE-STABLE FORMULAS OF SINCALIDE |